Welcome to Sherry Agabiti as a Postdoctoral Associate in the lab! Sherry completed her PhD from the University of Connecticut School of Pharmacology in October 2018. Sherry's prior work focused on studying the consequence of geranylgeranyl disphosphate synthase inhibition in cancer cells. As she starts in the lab, Sherry will be working on validating KRAS synthetic lethal targets and study clonal evolution in lung and pancreatic cancers.
Welcome to Sherry Agabiti!
November 01, 2018